It can be a confusing picture. Because SGLT-2 inhibitors increase the amount of sugar in urine, they can also increase your risk for urinary tract infections and vaginal infections, says Trence
The model, beginning in 2026 for Medicaid and 2027 for Medicare, is voluntary for drug manufacturers, state Medicaid programs, and Medicare Part D plans
Its become a popular medication for weight loss under various brand names
While patients may occasionally notice swollen lymph nodes during treatment, current clinical trial data and FDA prescribing information do not establish tirzepatide as a recognized cause of lymphadenopathy
Sancho V, Daniele G, Lucchesi D, et al
Some large drug cases later proceed as class actions or other coordinated litigation